Cancer

Items 31-40 of 133

per page
Set Descending Direction
  1. AS-703026
    CAS  1236699-92-5
    SYN-1190
    SYN-1190-M0011 mg
    CHF 85.00
    SYN-1190-M0055 mg
    CHF 128.00
    SYN-1190-M01010 mg
    CHF 170.00
    SYN-1190-M05050 mg
    CHF 553.00
    SYN-1190-M100100 mg
    CHF 922.00
    AS-703026
  2. Asiatic acid
    CAS  464-92-6
    AG-CN2-0400
    AG-CN2-0400-M0055 mg
    CHF 60.00
    AG-CN2-0400-M02525 mg
    CHF 240.00
    Asiatic acid
  3. AT7519 hydrochloride
    CAS  902135-91-5
    SYN-1010
    SYN-1010-M0011 mg
    CHF 85.00
    SYN-1010-M0055 mg
    CHF 142.00
    SYN-1010-M01010 mg
    CHF 213.00
    SYN-1010-M05050 mg
    CHF 766.00
    SYN-1010-M100100 mgINQ
    AT7519 hydrochloride
  4. AZ191
    CAS  1594092-37-1
    AG-CR1-3657
    AG-CR1-3657-M0011 mg
    CHF 35.00
    AG-CR1-3657-M0055 mg
    CHF 120.00
    AG-CR1-3657-M02525 mg
    CHF 450.00
    AZ191
  5. AZD-7762 hydrochloride
    CAS  1246094-78-9
    SYN-1017
    SYN-1017-M0011 mg
    CHF 114.00
    SYN-1017-M0055 mg
    CHF 142.00
    SYN-1017-M01010 mg
    CHF 227.00
    SYN-1017-M05050 mg
    CHF 695.00
    SYN-1017-M100100 mgINQ
    AZD-7762  hydrochloride
  6. Bakuchiol
    CAS  10309-37-2
    AG-CN2-0495
    AG-CN2-0495-M0011 mg
    CHF 40.00
    Bakuchiol
  7. Butyrolactone I
    CAS  87414-49-1
    BVT-0448
    BVT-0448-C200200 µg
    CHF 115.00
    BVT-0448-M0011 mg
    CHF 155.00
    BVT-0448-M0055 mg
    CHF 505.00
    Butyrolactone I
  8. Carfilzomib [PR-171]
    CAS  868540-17-4
    AG-CR1-3669
    AG-CR1-3669-M0011 mg
    CHF 40.00
    AG-CR1-3669-M0055 mg
    CHF 65.00
    AG-CR1-3669-M02525 mg
    CHF 110.00
    Carfilzomib [PR-171]
  9. CD38 (human) (rec.) (His) (active) (10µg)
    BBL-2275
    BBL-2275-C01010 µg
    CHF 782.00
    CD38 (human) (rec.) (His) (active) (10µg)
  10. Cephalochromin
    CAS  25908-26-3
    BVT-0440
    BVT-0440-M0011 mg
    CHF 170.00
    BVT-0440-M0055 mg
    CHF 505.00
    Cephalochromin

Items 31-40 of 133

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.